Drug Channels Archive for December, 2023

Click a link below to view the mailing archive as if it had been sent to you.

2023-12-20 07:47		Drug Channels News Roundup, December 2023: CVS's New GPO, Medicaid vs. PBMs, 340B in Part D, and a Rockin' Ex-CEO
2023-12-15 07:47		Drug Channels - EXCLUSIVE: The 340B Program Reached $54 Billion in 2022—Up 22% vs. 2021 (rerun)
2023-12-14 07:47		Drug Channels - The Battle for Oncology Margin: How Private Equity Enables Vertical Integration by Pharmaceutical Wholesalers (rerun)
2023-12-13 07:47		Drug Channels - White Bagging Update 2023: Saving Money or Shifting Costs? (rerun)
2023-12-12 07:47		Drug Channels - Surprising Data on Employer-PBM Rebate Pass-Through Arrangements in 2023 (rerun)
2023-12-11 07:47		Drug Channels - What's Behind CVS Health's Novel Vertical Integration Strategy for Humira Biosimilars (rerun)
2023-12-08 07:47		Drug Channels - Transforming Medication Access with the Next Generation of Patient Support Services
2023-12-07 07:47		Join me next Friday for the Drug Channels Outlook 2024
2023-12-06 07:47		Drug Channels - What CVS Pharmacy's New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices
2023-12-05 07:47		Drug Channels - Drug Wholesalers and Brand-Name Drug Prices: Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s
2023-12-01 07:47		Drug Channels - How Direct-to-Consumer Rx Platforms Help Patient Support Programs Succeed